ANL 36.25 Decreased By ▼ -0.30 (-0.82%)
ASC 14.75 Decreased By ▼ -0.05 (-0.34%)
ASL 25.90 Decreased By ▼ -0.20 (-0.77%)
AVN 89.68 Decreased By ▼ -1.22 (-1.34%)
BOP 7.80 No Change ▼ 0.00 (0%)
BYCO 10.16 Decreased By ▼ -0.05 (-0.49%)
DGKC 124.20 Decreased By ▼ -1.00 (-0.8%)
EPCL 57.65 Increased By ▲ 0.15 (0.26%)
FCCL 24.29 Decreased By ▼ -0.06 (-0.25%)
FFBL 29.07 Increased By ▲ 0.27 (0.94%)
FFL 15.91 Decreased By ▼ -0.14 (-0.87%)
HASCOL 9.71 Decreased By ▼ -0.08 (-0.82%)
HUBC 78.90 Decreased By ▼ -0.10 (-0.13%)
HUMNL 6.60 Decreased By ▼ -0.17 (-2.51%)
JSCL 21.65 Decreased By ▼ -0.16 (-0.73%)
KAPCO 40.00 Decreased By ▼ -0.10 (-0.25%)
KEL 3.78 Decreased By ▼ -0.05 (-1.31%)
LOTCHEM 16.62 Increased By ▲ 0.01 (0.06%)
MLCF 46.70 Decreased By ▼ -0.45 (-0.95%)
PAEL 35.40 Increased By ▲ 0.17 (0.48%)
PIBTL 10.30 Decreased By ▼ -0.05 (-0.48%)
POWER 9.28 Increased By ▲ 0.03 (0.32%)
PPL 86.50 Increased By ▲ 0.48 (0.56%)
PRL 25.22 Decreased By ▼ -0.10 (-0.39%)
PTC 9.98 Decreased By ▼ -0.03 (-0.3%)
SILK 1.24 No Change ▼ 0.00 (0%)
SNGP 42.90 Increased By ▲ 0.85 (2.02%)
TRG 163.88 Decreased By ▼ -0.87 (-0.53%)
UNITY 30.74 Decreased By ▼ -0.02 (-0.07%)
WTL 1.58 Increased By ▲ 0.10 (6.76%)
BR100 4,877 Increased By ▲ 3.76 (0.08%)
BR30 25,804 Decreased By ▼ -43.71 (-0.17%)
KSE100 45,321 Increased By ▲ 10.02 (0.02%)
KSE30 18,558 Increased By ▲ 14.03 (0.08%)

Coronavirus
VERY HIGH
Pakistan Deaths
15,872
11824hr
Pakistan Cases
739,818
539524hr
Sindh
270,310
Punjab
258,441
Balochistan
20,580
Islamabad
68,066
KPK
102,290
World

Single-shot COVID vaccine in UK could be weeks away

  • A senior government official says the Medicines and Healthcare products Regulatory Agency (MHRA) formal process was “very likely” to start this week
  • The jab, developed by Johnson & Johnson’s vaccine division Janssen, was not yet being considered by the MHRA for formal approval
28 Feb 2021

A single-shot vaccine to combat COVID-19 in Britain could be weeks away, with regulators set to begin the approval process this week, The Telegraph reported here.

A senior government source said the Medicines and Healthcare products Regulatory Agency (MHRA) formal process was “very likely” to start this week, according to the report.

The jab, developed by Johnson & Johnson’s vaccine division Janssen, was not yet being considered by the MHRA for formal approval, the report added, citing health sources.

“We are working with them to complete the rolling review process, and we look forward to receiving more data from them as soon as possible,” a department source told The Telegraph.

The news came as the United States is likely nearing the authorization of Johnson & Johnson’s COVID-19 vaccine. On Friday, a panel of outside advisers backed the one-shot immunization.